Cargando…
Improving the use of intravenous antihypertensive medications in the hospital setting: a quality improvement initiative for patient safety
Intravenous (IV) hydralazine, enalapril and labetalol are oftentimes used without indication for the treatment of asymptomatic hypertension in the hospital setting and have been shown to have substantial adverse effects that are associated with increased morbidity and mortality, as well as longer le...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BMJ Publishing Group
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6887509/ https://www.ncbi.nlm.nih.gov/pubmed/31803850 http://dx.doi.org/10.1136/bmjoq-2019-000626 |